Abstract:Background:Psoriasis is an immune-mediated inflammatory, genetic disease with numerous concomitant metabolic disorders1. Patients with psoriasis experience substantial morbidity and increased rates of cardiometabolic diseases2. Among the metabolic disorders, lipid disturbances are recognized as a very important part in the pathogenesis of psoriasis and psoriasis-associated cardiometabolic diseases3 4.Objectives:To characterize the molecular features of psoriasis by the development of a classification system that was based on the gene expression profile of lipid metabolism related genes.Methods:We performed molecular subtyping and association analysis of psoriasis from Gene Expression Omnibus (GEO). The training sets includes GSE13355 cohort (N = 58), GSE14905 (N = 28) cohort and GSE30999 cohort (N = 81), while the GSE54456 (N = 92) was selected as the validation set. Energy metabolism-related genes were collected from MSigDB (version 7.0; http://software.broadinstitute.org/gsea/msigdb/). Based on these psoriasis lipid metabolism-related genes, we conducted consensus molecular subtyping with nonnegative matrix factorization (NMF). Finally, Gene set variation analysis (GSVA) was used to score individual subtypes against the metabolism-related gene sets, and each group got a GSVA index.Results:Total 104 lipid metabolism-related genes were clustered into three subgroups (Figure 1A). GSVA revealed the lipid metabolism with the correlation in subtypes. There was no statistical difference was identified between the subtype 1 and subtype 2(P > 0.05, Figure 1B), so we merged the two types as a new Sub1, another subtype was named as the new Sub2 (Figure 1C). We finally identified 2 distinct subtypes of psoriasis in GEO cohort that were characterized by significantly different lipid metabolic gene score. Sub1 was featured by higher metabolic gene score compared with that of Sub2(P < 0.001; Figure 1D). The lipid metabolic subtype classification was successfully validated in another independent patient cohorts (GSE54456).Conclusion:This study established a new classification based on the gene expression profiles of lipid metabolic genes, thereby furthering the understanding of the pathogenesis and psoriasis-associated diseases.References:[1]Boehncke WH, Schon MP. Psoriasis. Lancet 2015;386(9997):983-94. doi: 10.1016/S0140-6736(14)61909-7 [published Online First: 2015/05/31].[2]Armstrong AW, Read C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA 2020;323(19):1945-60. doi: 10.1001/jama.2020.4006 [published Online First: 2020/05/20].[3]Goolam Mahyoodeen N, Crowther NJ, Pillay L, et al. Relationship of Visceral Fat and Adipokines with Cardiometabolic Diseases in Psoriasis. Acta Derm Venereol 2019;99(13):1218-23. doi: 10.2340/00015555-3327 [published Online First: 2019/10/04].[4]Pietrzak A, Michalak-Stoma A, Chodorowska G, et al. Lipid disturbances in psoriasis: an update. Mediators Inflamm 2010;2010 doi: 10.1155/2010/535612 [published Online First: 2010/08/14].Acknowledgements:This project was supported by National Science Foundation of China (82001740), Open Fund from the Key Laboratory of Cellular Physiology (Shanxi Medical University) (KLCP2019) and Innovation Plan for Postgraduate Education in Shanxi Province (2020BY078).Disclosure of Interests:None declared

Lipidomics Profiling Reveals the Role of Glycerophospholipid Metabolism in Psoriasis

Lipidomic profiling reveals metabolic signatures in psoriatic skin lesions

POS0353 DEEP PHENOTYPING OF PSORIASIS BASED ON LIPID METABOLISM RELATED GENES BY INTEGRATIVE SYSTEMS ANALYSIS

Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis

Exploration of circulating metabolic signature of erythrodermic psoriasis based on LC‐MS metabolomics

Abnormal lipid metabolism in epidermal Langerhans cells mediates psoriasis-like dermatitis

Exploration of Candidate Biomarkers for Human Psoriasis Based on Gas Chromatography-Mass Spectrometry Serum Metabolomics

Lysophosphatidylcholine facilitates the pathogenesis of psoriasis through activating keratinocytes and T cells differentiation via glycolysis

Phospholipase A2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris

Metabolic Profiling Reveals Interleukin-17A Monoclonal Antibody Treatment Ameliorate Lipids Metabolism with the Potentiality to Reduce Cardiovascular Risk in Psoriasis Patients

High-throughput transcriptome and pathogenesis analysis of clinical psoriasis

Integrated skin microbiome and metabolome analyses reveal altered bacterial community composition and metabolites in psoriasis

Integrated bioinformatic analysis of key biomarkers and signalling pathways in psoriasis

Single-cell and bulk RNAseq unveils the immune infiltration landscape and targeted therapeutic biomarkers of psoriasis

The impacts of biologic treatment on metabolic profiling in psoriasis

LC-MS/MS analysis of lesional and normally looking psoriatic skin reveals significant changes in protein metabolism and RNA processing

Advance in Multi-omics Research Strategies on Cholesterol Metabolism in Psoriasis

Exploring the pathogenesis and immunological profiles of psoriasis complicated with MASLD

In-depth serum proteomics reveals biomarkers of psoriasis severity and response to traditional Chinese medicine

Proteomic analysis of psoriatic skin lesions in a Chinese population

Assessing the genetic associations between plasma lipidomic profiles and psoriasis vulgaris